CClinicalTrials.gg
CompletedNCT05894473Updated Jun 22, 2026

Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease

An interventional study of Motor-Motor Dual Task Physical Exercises in Parkinson Disease, sponsored by Yeditepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 87 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-22.

Sponsored by Yeditepe University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years to 87 Years
Sex
All
01

Study summary

The ability to respond to multiple stimuli is impaired in Parkinson's patients. Traditional rehabilitation approaches focus only on balance and gait training, but individuals with Parkinson's disease need to perform multiple tasks in daily life.

Read the detailed description

The dual-task (DT) methodology aims to perform two tasks simultaneously. There is no study in which motor and cognitive dual-task exercises are given together and followed up remotely in elderly individuals with PD.

Therefore, it was aimed to compare the effects of telerehabilitation method and motor and cognitive dual-task exercises on cognitive function, balance, walking, fall risk and quality of life in individuals with Parkinson's Disease.

02

Conditions studied

  • Parkinson Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 30 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Yeditepe University is the lead sponsor of 127 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 87 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being diagnosed with idiopathic Parkinson's Disease

    • Getting at least 21 points from the Montreal Cognitive Assessment Scale test
    • Stability of drug therapy taken in the last 1 month
    • Being in the "ten" period of the patients
    • Being able to walk independently on flat ground (4 and above according to Functional Ambulation Classification)

Exclusion criteria

Exclusion Criteria:

    • Serious hearing or vision problems

      • Having other neurological, cardiovascular or orthopedic disorders that may prevent walking
      • Any other neurological disorder (eg dementia, cerebrovascular disease)
      • Having an education level of less than 5 years
      • Patients with a pacemaker
      • Having vascular lower extremity pathologies
      • Not having internet access with a smart phone or computer
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Motor-Motor Dual Task Training Exercises

    Motor-Motor Dual Task Physical Exercises will be given to the participants

    Other: Motor-Motor Dual Task Physical Exercises

  • Active comparator
    Cognitive-Motor Dual Task Training Exercises

    Cognitive-Motor Dual Task Physical Exercises will be given to the participants

    Other: Motor-Motor Dual Task Physical Exercises

  • Active comparator
    Structured exercise program

    Physical exercise will be given to the participants

    Other: Motor-Motor Dual Task Physical Exercises

Interventions

  • OtherMotor-Motor Dual Task Physical Exercises

    Only physical exercise and motor dual tasks will be given

06

What researchers measure

Primary outcomes

  1. Parkinson's Disease Quality of Life Questionnaire

    Parkinson's Disease Quality of Life Questionnaire

    Time frame: 8 weeks

  2. Montreal Cognitive Assessment Scale (MoCA)

    Montreal Cognitive Assessment Scale (MoCA)

    Time frame: 8 weeks

  3. Berg Balance Scale (BBS)

    Berg Balance Scale (BBS)

    Time frame: 8 weeks

  4. 10 meter walking speed test

    10 meter walking speed test

    Time frame: 8 weeks

  5. Timed Up And Go Test

    Timed Up And Go Test

    Time frame: 8 weeks

  6. Fall Efficiency Scale - International

    Fall Efficiency Scale - International

    Time frame: 8 weeks

  7. Five Times Sit to Stand Test

    Five Times Sit to Stand Test

    Time frame: 8 weeks

07

Study locations

1 site
  • Yeditepe University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05894473
Lead sponsor
Yeditepe University
Responsible party
Ebru Akbuğa Koç (Assistant Professor, Yeditepe University) — Principal investigator
First posted
Jun 8, 2023
Start date
May 30, 2023
Primary completion
Jul 14, 2023
Completion
Aug 1, 2023
Last update
Jun 22, 2026

Study contacts

Yeditepe University
principal investigator · Yeditepe University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion